This is Measles If You've Never Seen It
Here, the 5 key signs and symptoms that characterize measles in the order of appearance.
Measles and the Collective American Memory: 3 Questions
Measles cases are edging up in the US again as MMR vaccination rates continue to decline. Have parents forgotten the Ohio outbreak of 2022? Have you? Find out, here.
Nirsevimab Effective Against RSV Hospitalization among Infants: Daily Dose
Your daily dose of the clinical news you may have missed.
Blood-Based DNA Test Shows Sensitivity of 83% for Colorectal Cancer
Findings from the ECLIPSE clinical trial showed the blood-based cancer screening test detects 83% of people with CRC, with a specificity of 90%.
Optinose Xhance approved by FDA as first medical therapy for CRS
Now FDA approved, Optinose’s Xhance is the first nonsurgical option for chronic rhinosinusitis both with and without nasal polyps.
Dyslipidemia in American Indian Youth: Daily Dose
Madrigal's Resmetirom Wins Historic FDA Approval for Noncirrhotic NASH
Resmetirom is the first-ever drug to be approved anywhere for management of the progressive liver disease.
Plastic Debris in Carotid Plaque Linked to CV Events: Daily Dose
AstraZeneca Launches Phase 3 THARROS Trial of Breztri to Reduce Cardiopulmonary Events in COPD
THARROS is the first phase 3 RCT to evaluate an inhaled triple combination therapy for reduction of adverse cardiopulmonary events in people with COPD, says AstraZeneca.
KDIGO Releases 2024 Clinical Practice Guideline for Evaluation and Management of CKD
The KDIGO 2024 CKD Practice Guideline is the first update since the 2012 iteration and so is based on the newest research on treatment and technology available.
Aspirin Use among Older Adults Inconsistent with Current Guidelines, According to New Survey
In a survey of adults aged 50-80 years, 57% of those who reported taking aspirin regularly said they do not have a history of CVD.
Antisense Molecule against MASH from Ionis Meets Primary Endpoint in Phase 2 Trial
Ionis reports the first clinical evidence that DGAT2 inhibition-driven reduction of hepatic fat correlates with improvements in MASH histologic endpoints.
In Pregnant Women with T1D, Higher Time-in-Range Improves Maternal, Neonatal Outcomes: Daily Dose
Chronic Kidney Disease in Primary Care: Essential Basics Review
Primary care plays an essential role in identifying CKD, monitoring and slowing disease progression, and providing timely referral, when indicated, to nephrology.
Pegazofermin Enters Phase 3 ENLIGHTEN Clinical Trial Program for MASH
The 2 phase 3 trials in the 89bio ENLIGHTEN clinical trial program will evaluate the safety and efficacy of the FGF21 analog in MASH, fibrosis.
First Issue of Patient Care Online Digital Edition Goes Live
The inaugural digital issue of Patient Care focuses on the antiobesity and type 2 diabetes medications, semaglutide and tirzepatide.
Risk of Stroke Mitigated by Even Low Levels of Physical Activity
Even activity levels considered "insufficient" by guideline standards were found protective against stroke in this new systematic review and meta-analysis.
Early Detection of CKD Progression in Primary Care: Daily Dose
Could Prior Authorization Work Win its Own CPT Code?
A CPT code for time spent petitioning insurance companies to approve patient prescriptions has been proposed before; sentiment was not unanimous.
Tapinarof Cream 1.0% Effective for Atopic Dermatitis in Persons with Skin of Color: ADORING Phase 3 Program
Study participants self-identified as Black, White, or Asian and significant proportions reached improvement of ≥75% in EASI in both in ADORING 1 and ADORING-2.
